Zeltia SA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Zeltia SA Plans Merger By Incorporation With Its Wholly Owned Subsidiary And Bonus Shares Issuance
Zeltia SA announced that is planning a merger by incorporation with its wholly owned subsidiary, Sociedad Proteccion De Maderas SA. The merger proposal will be submitted to the shareholder for the approval at the Ordinary and Extraordinary Shareholders Meeting to be celebrated on June 12, 2012. During the meeting the Company will also propose a plan of bonus shares issuance for the fiscal year 2013, at the maximum amount of 350,000 shares of Zeltia for employees who meet certain conditions.
Latest Developments for Zeltia SA
Latest Key Developments in Biotechnology
- BioSpecifics Technologies Corp announces board authorization of up to $2 million stock repurchase program
- Insys Therapeutics Inc receives subpoena from Office of Inspector General
- Synta Pharmaceuticals Corp announces positive interim results from the ENCHANT-1 Trial
- Celator Pharmaceuticals Inc announces positive data and safety monitoring board recommendation for CPX-351 Phase 3 Study
- Share this
- Digg this